BOSTON SCIENTIFIC CORP - COMMON STOCK (BSX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
BSX on NYSE
Shares outstanding
1,470,945,837
Price per share
$95.35
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,336,450,694
Total reported value
$130,384,955,834
% of total 13F portfolios
0.06%
Share change
-15,379,107
Value change
-$1,754,236,340
Number of holders
1,686
Price from insider filings
$95.35
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BOSTON SCIENTIFIC CORP - COMMON STOCK (BSX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.6% $10,344,630,663 113,006,671 BlackRock, Inc. 31 Mar 2025
FMR LLC 7.5% -21% $11,499,854,557 -$3,213,598,699 110,320,938 -22% FMR LLC 30 Jun 2025

As of 30 Sep 2025, 1,686 institutional investors reported holding 1,336,450,694 shares of BOSTON SCIENTIFIC CORP - COMMON STOCK (BSX). This represents 91% of the company’s total 1,470,945,837 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BOSTON SCIENTIFIC CORP - COMMON STOCK (BSX) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.9% 145,175,869 -1% 0.25% $14,173,520,098
VANGUARD GROUP INC 9.4% 138,249,447 +0.81% 0.2% $13,497,293,511
FMR LLC 6.8% 99,477,701 -8.2% 0.5% $9,712,007,926
STATE STREET CORP 4.4% 64,925,564 -0.41% 0.22% $6,338,682,813
BANK OF AMERICA CORP /DE/ 2.3% 33,869,041 +0.07% 0.25% $3,306,634,494
PRIMECAP MANAGEMENT CO/CA/ 2.3% 33,102,094 -4.5% 2.5% $3,231,757,439
GEODE CAPITAL MANAGEMENT, LLC 2.2% 32,690,528 +0.82% 0.2% $3,176,949,765
JPMORGAN CHASE & CO 1.9% 28,329,209 +10% 0.18% $2,765,812,643
Capital World Investors 1.8% 26,648,948 -6.6% 0.36% $2,601,693,412
MORGAN STANLEY 1.4% 20,714,248 +2.2% 0.12% $2,022,332,304
Bollard Group LLC 1.3% 19,733,573 -1.7% 48% $1,926,589,000
Invesco Ltd. 1.2% 16,963,344 +0.66% 0.26% $1,656,131,314
GOLDMAN SACHS GROUP INC 1% 15,005,259 +7.7% 0.21% $1,464,963,499
WELLINGTON MANAGEMENT GROUP LLP 1% 14,653,441 -55% 0.25% $1,430,615,446
NORTHERN TRUST CORP 0.98% 14,402,636 +0.9% 0.18% $1,406,129,352
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 0.95% 14,032,541 -16% 1.2% $1,369,996,973
Amundi 0.81% 11,981,584 +17% 0.37% $1,158,619,174
JANUS HENDERSON GROUP PLC 0.81% 11,971,870 -1.5% 0.53% $1,168,810,184
Bank of New York Mellon Corp 0.75% 11,032,972 -1.6% 0.19% $1,077,149,027
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.75% 10,978,385 -14% 0.23% $1,071,819,728
UBS Group AG 0.72% 10,567,142 -8.1% 0.2% $1,031,670,073
Legal & General Group Plc 0.71% 10,457,175 +4.6% 0.23% $1,020,934,001
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.7% 10,367,293 -19% 0.31% $1,012,158,815
MARSHALL WACE, LLP 0.67% 9,799,040 +31% 1.1% $956,680,277
Nuveen, LLC 0.66% 9,646,238 +2% 0.25% $941,762,216

Institutional Holders of BOSTON SCIENTIFIC CORP - COMMON STOCK (BSX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 11,226,003 $1,070,579,287 +$124,488,536 $95.35 137
2025 Q3 1,336,450,694 $130,384,955,834 -$1,754,236,340 $97.63 1,686
2025 Q2 1,350,469,260 $144,909,365,677 +$3,628,519,940 $107.41 1,672
2025 Q1 1,316,410,619 $132,617,505,327 -$1,400,413,086 $100.88 1,615
2024 Q4 1,335,207,947 $119,291,865,525 +$2,581,076,751 $89.32 1,477
2024 Q3 1,299,647,741 $108,919,647,528 -$2,282,415,557 $83.80 1,376
2024 Q2 1,324,560,257 $101,937,964,066 +$2,359,027,341 $77.01 1,297
2024 Q1 1,303,609,336 $89,276,809,166 -$804,525,255 $68.49 1,205
2023 Q4 16,820,706 $971,233,721 -$240,349,597 $57.81 23
2023 Q3 1,318,002,895 $69,550,720,082 +$674,525,396 $52.80 1,027
2023 Q2 1,304,644,762 $70,526,957,372 -$145,484,641 $54.09 1,039
2023 Q1 1,307,485,043 $65,433,298,115 +$343,515,304 $50.03 965
2022 Q4 1,266,582,733 $58,637,102,618 -$333,723,879 $46.27 896
2022 Q3 1,299,712,719 $50,432,102,615 +$319,726,609 $38.73 823
2022 Q2 1,296,881,048 $48,365,744,700 +$861,128,930 $37.27 838
2022 Q1 1,272,670,130 $56,406,955,618 -$235,264,632 $44.29 871
2021 Q4 1,284,179,807 $54,599,911,984 -$449,655,882 $42.48 861
2021 Q3 1,300,738,205 $56,460,767,818 +$415,770,569 $43.39 861
2021 Q2 1,290,470,361 $55,199,847,654 +$24,231,030 $42.76 848
2021 Q1 1,288,645,986 $49,818,337,173 +$807,307,108 $38.65 812
2020 Q4 1,244,703,718 $44,757,908,355 -$1,418,796,709 $35.95 835
2020 Q3 1,265,758,470 $48,375,284,475 +$149,451,142 $38.21 825
2020 Q2 1,300,470,530 $45,669,815,838 +$1,083,767,896 $35.11 813
2020 Q1 1,243,066,282 $40,579,785,231 -$543,905,081 $32.63 769
2019 Q4 1,280,111,410 $57,890,426,506 -$225,552,484 $45.22 826
2019 Q3 1,282,442,578 $52,191,091,972 -$249,254,832 $40.69 754
2019 Q2 1,288,117,735 $55,309,652,312 +$1,904,322,383 $42.98 733
2019 Q1 1,275,502,511 $48,946,899,601 +$117,322,506 $38.38 770
2018 Q4 1,272,879,508 $44,980,807,941 -$120,681,890 $35.34 712
2018 Q3 1,269,668,357 $48,876,692,879 -$138,911,403 $38.50 687
2018 Q2 1,275,284,654 $41,698,448,102 +$1,504,808,178 $32.70 661
2018 Q1 1,247,650,459 $34,082,543,688 -$82,743,302 $27.32 614
2017 Q4 1,243,229,007 $30,824,061,719 -$192,709,259 $24.79 618
2017 Q3 1,257,868,252 $36,665,834,495 +$153,839,459 $29.17 535
2017 Q2 1,253,075,221 $34,734,401,359 +$539,761,391 $27.72 543
2017 Q1 1,264,159,507 $31,439,984,601 +$2,328,595,904 $24.87 534
2016 Q4 1,256,814,584 $27,186,911,619 +$98,288,269 $21.63 546
2016 Q3 1,236,103,415 $29,402,118,598 -$351,744,784 $23.80 554
2016 Q2 1,251,351,734 $29,241,983,096 +$110,947,731 $23.37 536
2016 Q1 1,245,689,330 $23,425,657,494 +$445,998,079 $18.81 482
2015 Q4 1,246,515,984 $22,984,667,992 -$14,266,747 $18.44 489
2015 Q3 1,222,863,890 $20,065,958,369 +$563,158,895 $16.41 467
2015 Q2 1,197,749,163 $21,199,180,226 +$207,241,678 $17.70 459
2015 Q1 1,200,527,030 $21,294,800,875 +$119,425,588 $17.75 461
2014 Q4 1,196,066,508 $15,855,363,403 +$29,425,259 $13.25 446
2014 Q3 1,191,183,998 $14,066,745,503 +$82,069,069 $11.81 425
2014 Q2 1,163,460,740 $14,856,210,089 +$446,112,615 $12.77 446
2014 Q1 1,135,484,131 $15,345,708,875 -$195,854,844 $13.52 429